The Latest From RWEOne
Official press releases, product announcements, partnership updates, regulatory milestones, awards, and industry news from the RWEOne team — curated for clinical operations leaders, procurement, and press.
RWEOne Expands Asia-Pacific Site Network to 18 New Countries
RWEOne announces the expansion of its global investigator site network across 18 new Asia-Pacific markets, enabling rapid rare-disease and oncology study activation in the region.
RWEOne EDC Platform Achieves CDISC CDASH 2026 Certification
The RWEOne Electronic Data Capture platform has received official CDISC CDASH 2026 standard certification, validating the eCRF builder's out-of-the-box standards alignment.
RWEOne Awarded 'Best RWE Solution 2026' at Global Pharma Tech Awards
RWEOne recognized as the Best Real-World Evidence solution of 2026 by the Global Pharma Tech Awards, citing AI-driven validation and RabbitMQ-powered audit trail innovations.
Top-15 Global Pharma Signs Multi-Year Enterprise RWEOne Platform License
A top-15 global biopharmaceutical company has entered a multi-year enterprise agreement to deploy the RWEOne platform across its oncology, cardiovascular, and immunology Phase 1-4 portfolios.
RWEOne Launches AI Validation Engine v4 with Predictive SDV
Version 4 of the RWEOne AI-driven validation engine introduces predictive source-data-verification prioritization, reducing manual SDV workload by an additional 35% vs. the v3 baseline.
RWEOne to Present at DIA Global 2026: The Future of Clinical Data
RWEOne's Chief Scientific Officer will present at the DIA Global 2026 Annual Meeting on the topic of AI-enabled real-world evidence and continuous lifecycle evidence generation.
RWEOne Completes Annual GxP and 21 CFR Part 11 Platform Revalidation Audit
The RWEOne platform has successfully completed its annual third-party GxP and 21 CFR Part 11 revalidation audit, with zero findings across 142 audited controls.
RWEOne Launches Rare Disease Center of Excellence
A dedicated Rare Disease Center of Excellence has been established within RWEOne, led by a world-class scientific advisory board spanning 8 ultra-rare indications.
RWEOne Media & Press Resources
For journalists, analysts, and industry publications: access the RWEOne brand toolkit, executive bios, image assets, and the press contact for briefings.
Brand Toolkit & Logos
ZIP with high-res RWEOne brand assets
Executive Bios & Headshots
Leadership team bios and photography
Press Contact
[email protected] — response under 4 business hours